curacle co., ltd.
A clinical-stage biopharma developing drugs for intractable vascular diseases.
365270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7365270008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 효령로 23-1, 서울특별시
- Website:
- http://www.curacle.com/eng/main/
Description
Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-12 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-02-10 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-02-06 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.4 KB | ||
| 2024-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2024-12-05 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등) (중증도 내지 중증 궤양성 대장염에 대한 CU104의 제2상 임상시험계획…
|
Korean | 12.7 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 728.2 KB | ||
| 2024-08-28 00:00 |
전환가액의조정 (제1회차)
|
Korean | 11.3 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 905.7 KB | ||
| 2024-07-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 120.2 KB | ||
| 2024-07-12 00:00 |
불성실공시법인지정 (공시불이행 1건, 공시번복 1건)
|
Korean | 7.0 KB | ||
| 2024-07-02 00:00 |
[기재정정]불성실공시법인지정예고 (공시불이행 1건, 공시번복 1건)
|
Korean | 9.4 KB | ||
| 2024-06-24 00:00 |
[기재정정]불성실공시법인지정예고 (공시불이행)
|
Korean | 8.2 KB | ||
| 2024-06-20 00:00 |
불성실공시법인지정예고 (공시불이행)
|
Korean | 5.1 KB | ||
| 2024-06-14 00:00 |
[기재정정]투자판단관련주요경영사항 (당뇨병성 황반부종 및 습성 황반변성 치료제 CU06-RE 기술이전License-Ou…
|
Korean | 9.8 KB | ||
| 2024-06-12 00:00 |
[기재정정]투자판단관련주요경영사항 (당뇨병성 황반부종 및 습성 황반변성 치료제 CU06-RE 기술이전License-Ou…
|
Korean | 9.5 KB |
Automate Your Workflow. Get a real-time feed of all curacle co., ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for curacle co., ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for curacle co., ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
